VU0155069 PLD inhibitor Potent and specific inhibitor of phospholipase D1 (PLD1) in cellular (PLD1 IC50 = 11nM Calu-1 cells; PLD2 IC50 = 1800nM HEK293-gfpPLD2 cells) and in vitro (hPLD1 IC50 = 46nM; hPLD2 IC50 = 933nM) assays. Significantly decreases invasive migration in breast cancer cell lines (MDA-231, 4T1 and PMT). Product Specification Alternative Name: N-[(2S)-1-[4-(5-Chloro-2-oxo-3H-benzimidazol-1-yl)-piperidin-1-yl]-propan-2-yl]naphthalene-2-carboxamide Formula: C26H27ClN4O2 MW: 463.0 CAS: 1130067-06-9 Purity: ≥98% (TLC) Appearance: Pale-yellow solid. Solubility: Soluble in DMSO (>25mg/ml) or 100% ethanol (>25mg/ml). Long Term Storage: -20°C